Annual report pursuant to Section 13 and 15(d)

Schedule of Deferred Tax Assets and Liabilities (Details)

v3.24.1
Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 22,005 $ 21,368
Compensation 583 474
Research and development tax credits 3,196 2,710
Capitalized and Research Expenditures 5,288 2,595
Other 848 487
Total deferred tax assets 31,920 27,633
Property and equipment (29) (27)
Other (410) (60)
Total deferred tax liabilities (439) (87)
Total deferred taxes, net 31,481 27,546
Valuation allowance (31,481) (27,546)
Deferred tax liability, net